Activity of arginine-phenylalanine and arginine-tryptophan-based surfactants against Staphylococcus aureus

Future Microbiol. 2022 Nov:17:1363-1379. doi: 10.2217/fmb-2022-0074. Epub 2022 Sep 28.

Abstract

Aims: This study aimed to evaluate the antibacterial effect of two new cationic surfactants based on phenylalanine-arginine (LPAM) and tryptophan-arginine (LTAM). Materials & methods: Antibacterial activity, mechanism of action and interactions with Staphylococcus aureus enzymes were measured through microbiological, flow cytometry and molecular docking assays, respectively. Results & conclusion: These compounds showed antibacterial activity in the range of 4.06-16.24 μg/ml against planktonic cells and no activity against mature biofilms, since they caused a loss of membrane integrity and increased DNA damage, as revealed by flow cytometry analysis. In silico assays revealed the existence of molecular bonds such as hydrogen bonds, mainly with DNA. Therefore, these compounds have promising pharmacological activity against MRSA strains.

Keywords: MRSA; amino acid-based surface-active agents; antibacterial; flow cytometry.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology
  • Arginine / chemistry
  • Arginine / pharmacology
  • Biofilms
  • Humans
  • Methicillin-Resistant Staphylococcus aureus*
  • Microbial Sensitivity Tests
  • Molecular Docking Simulation
  • Phenylalanine / pharmacology
  • Staphylococcal Infections* / drug therapy
  • Staphylococcus aureus
  • Surface-Active Agents / pharmacology
  • Tryptophan / pharmacology

Substances

  • Tryptophan
  • Arginine
  • Surface-Active Agents
  • Anti-Bacterial Agents
  • Phenylalanine